Last reviewed · How we verify

NCT06141928

Comparison of Three Different Surgical Approaches on the Functional Outcome After Total Hip Arthroplasty

Status unknown NA Last updated 21 November 2023
What this trial tests

NA trial testing Functional recovery analysis in Total Hip Arthroplasty in 100 participants. Status unknown.

Timeline
1 September 2021
Primary endpoint
31 December 2024
31 December 2025

Quick facts

Lead sponsorClinic for Orthopedics Lovran
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment100
Start date1 September 2021
Primary completion31 December 2024
Estimated completion31 December 2025
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

Clinic for Orthopedics Lovran

Who can join

Eligibility, any sex, with Total Hip Arthroplasty or Functional Recovery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to determine differences in functional recovery after total hip arthroplasty between a group of patients operated on using a direct lateral approach, an anterolateral minimally invasive approach, and a posterior approach to the hip joint. Arthroplasty is the most commonly performed surgical procedure in orthopedics and is also considered the gold standard for treating the final stage of osteoarthritis. There are several different approaches, but there are still conflicting studies that talk about the benefits of a particular approach. There is an insufficient number of scientific, prospective studies that monitor the basic functional and rehabilitation parameters, which are also indicators of the success of the performed procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Total Hip Arthroplasty

Currently open trials in the same condition.

Other Clinic for Orthopedics Lovran trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06141928.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing